byiShook Opinion
Dec 12, 2024 - 11:25
Keros Therapeutics stock plummeted Thursday after the company stopped giving higher doses in a lung disease study due to side effects. The post Keros Plummets 77% After Unexpected Side Effects 'Shock' Its Lead Drug appeared first on Investor's Business Daily.
Keros Therapeutics stock plummeted Thursday after the company stopped giving higher doses in a lung disease study due to side effects.
The post Keros Plummets 77% After Unexpected Side Effects 'Shock' Its Lead Drug appeared first on Investor's Business Daily.